FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885162604> ?p ?o ?g. }

• W2885162604 abstract "The highly refractory nature of non-small cell lung cancer (NSCLC) to chemotherapeutic drugs is an important factor resulting in its poor prognosis. Recent studies have revealed that tumour necrosis factor alpha-induced protein 8 (TNFAIP8) is involved in various biological and pathological processes of cells, but their underlying mechanisms in processes ranging from cancer development to drug resistance have not been fully elucidated. TNFAIP8 expression in clinical NSCLC samples was examined through immunohistochemistry (IHC). After adjusting for patients’ characteristics with propensity score matching, Kaplan-Meier analysis and Cox regression analysis were performed for comparison of patients’ survival according to the TNFAIP8 level. Lentiviral transfection with TNFAIP8-specific shRNAs was used to establish stable TNFAIP8 knockdown (TNFAIP8 KD) NCI-H460, A549 and cis-diamminedichloroplatinum II resistant A549 (A549/cDDP) cell lines. Cell proliferation and viability were assessed by CCK-8 assay. Cell cycle was examined by flow cytometry. Multiple pathways regulated by TNFAIP8 KD were revealed by microarray analysis. We found that high TNFAIP8 expression was associated with advanced pT stage, advanced pTNM stage, lymph node metastasis and unfavourable survival in NSCLC patients. TNFAIP8 shRNAs reduced in vitro cancer cell proliferation and in vivo tumor growth. Additionally, TNFAIP8 KD increased the sensitivity of NSCLC cells to cisplatin in vitro and in vivo. Conversely, up-regulation of TNFAIP8 promoted the proliferation and drug resistance to cisplatin of NSCLC cells. TNFAIP8 influences cancer progression pathways involving the MDM2/p53 pathway. Indeed, we observed that TNFAIP8 KD mediated the MDM2 downregulation and the p53 ubiquitination, thereby decreasing the degradation of p53 protein. shRNA p53 reversed TNFAIP8 shRNA-mediated regulation of cell proliferation, cell cycle, cisplatin sensitivity, and expression levels of RAD51, a DNA repair gene. Our work uncovers a hitherto unappreciated role of TNFAIP8 in NSCLC proliferation and cisplatin chemoresistance that is mediated through the MDM2/p53 pathway. These findings might offer potential therapeutic targets for reversing cisplatin resistance in NSCLC patients with high TNFAIP8 expression." @default.
• W2885162604 created "2018-08-22" @default.
• W2885162604 creator A5008074653 @default.
• W2885162604 creator A5009940394 @default.
• W2885162604 creator A5027317134 @default.
• W2885162604 creator A5031105368 @default.
• W2885162604 creator A5045891159 @default.
• W2885162604 creator A5050664289 @default.
• W2885162604 creator A5053763641 @default.
• W2885162604 creator A5057561095 @default.
• W2885162604 creator A5068080767 @default.
• W2885162604 creator A5075035689 @default.
• W2885162604 creator A5077791798 @default.
• W2885162604 creator A5078687129 @default.
• W2885162604 creator A5088027886 @default.
• W2885162604 date "2018-07-31" @default.
• W2885162604 modified "2023-10-14" @default.
• W2885162604 title "TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway" @default.
• W2885162604 cites W1485829830 @default.
• W2885162604 cites W1504277962 @default.
• W2885162604 cites W1890766043 @default.
• W2885162604 cites W1947613625 @default.
• W2885162604 cites W1985262467 @default.
• W2885162604 cites W1987604182 @default.
• W2885162604 cites W1990317973 @default.
• W2885162604 cites W1997249154 @default.
• W2885162604 cites W2006656221 @default.
• W2885162604 cites W2011727075 @default.
• W2885162604 cites W2029436213 @default.
• W2885162604 cites W2032575714 @default.
• W2885162604 cites W2041855451 @default.
• W2885162604 cites W2041929141 @default.
• W2885162604 cites W2054894788 @default.
• W2885162604 cites W2065484491 @default.
• W2885162604 cites W2072803155 @default.
• W2885162604 cites W2074699503 @default.
• W2885162604 cites W2077127766 @default.
• W2885162604 cites W2113349101 @default.
• W2885162604 cites W2129062251 @default.
• W2885162604 cites W2129533679 @default.
• W2885162604 cites W2141371351 @default.
• W2885162604 cites W2144762330 @default.
• W2885162604 cites W2147275279 @default.
• W2885162604 cites W2151986118 @default.
• W2885162604 cites W2162471107 @default.
• W2885162604 cites W2164277862 @default.
• W2885162604 cites W2404243046 @default.
• W2885162604 cites W2549285612 @default.
• W2885162604 cites W2552994841 @default.
• W2885162604 cites W2570618306 @default.
• W2885162604 cites W2572746721 @default.
• W2885162604 cites W2582367037 @default.
• W2885162604 cites W2583345756 @default.
• W2885162604 cites W2752942423 @default.
• W2885162604 cites W2915478882 @default.
• W2885162604 doi "https://doi.org/10.1186/s12964-018-0254-x" @default.
• W2885162604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6069800" @default.
• W2885162604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30064446" @default.
• W2885162604 hasPublicationYear "2018" @default.
• W2885162604 type Work @default.
• W2885162604 sameAs 2885162604 @default.
• W2885162604 citedByCount "51" @default.
• W2885162604 countsByYear W28851626042018 @default.
• W2885162604 countsByYear W28851626042019 @default.
• W2885162604 countsByYear W28851626042020 @default.
• W2885162604 countsByYear W28851626042021 @default.
• W2885162604 countsByYear W28851626042022 @default.
• W2885162604 countsByYear W28851626042023 @default.
• W2885162604 crossrefType "journal-article" @default.
• W2885162604 hasAuthorship W2885162604A5008074653 @default.
• W2885162604 hasAuthorship W2885162604A5009940394 @default.
• W2885162604 hasAuthorship W2885162604A5027317134 @default.
• W2885162604 hasAuthorship W2885162604A5031105368 @default.
• W2885162604 hasAuthorship W2885162604A5045891159 @default.
• W2885162604 hasAuthorship W2885162604A5050664289 @default.
• W2885162604 hasAuthorship W2885162604A5053763641 @default.
• W2885162604 hasAuthorship W2885162604A5057561095 @default.
• W2885162604 hasAuthorship W2885162604A5068080767 @default.
• W2885162604 hasAuthorship W2885162604A5075035689 @default.
• W2885162604 hasAuthorship W2885162604A5077791798 @default.
• W2885162604 hasAuthorship W2885162604A5078687129 @default.
• W2885162604 hasAuthorship W2885162604A5088027886 @default.
• W2885162604 hasBestOaLocation W28851626041 @default.
• W2885162604 hasConcept C104317684 @default.
• W2885162604 hasConcept C121608353 @default.
• W2885162604 hasConcept C126322002 @default.
• W2885162604 hasConcept C127561419 @default.
• W2885162604 hasConcept C143998085 @default.
• W2885162604 hasConcept C1491633281 @default.
• W2885162604 hasConcept C173396325 @default.
• W2885162604 hasConcept C203014093 @default.
• W2885162604 hasConcept C2776192174 @default.
• W2885162604 hasConcept C2776256026 @default.
• W2885162604 hasConcept C2776694085 @default.
• W2885162604 hasConcept C2778239845 @default.
• W2885162604 hasConcept C2779013556 @default.
• W2885162604 hasConcept C29537977 @default.
• W2885162604 hasConcept C502942594 @default.
• W2885162604 hasConcept C53227056 @default.
• W2885162604 hasConcept C54355233 @default.

• next